Page last updated: 2024-10-21

sk&f 81297 and Movement Disorders

sk&f 81297 has been researched along with Movement Disorders in 3 studies

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lasseter, HC1
Xie, X1
Arguello, AA1
Wells, AM1
Hodges, MA1
Fuchs, RA1
Dupre, KB1
Eskow, KL1
Barnum, CJ1
Bishop, C1
Lublin, H1

Other Studies

3 other studies available for sk&f 81297 and Movement Disorders

ArticleYear
Contribution of a mesocorticolimbic subcircuit to drug context-induced reinstatement of cocaine-seeking behavior in rats.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:3

    Topics: Analysis of Variance; Animals; Benzazepines; Cocaine; Cocaine-Related Disorders; Conditioning, Opera

2014
Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
    Neuropharmacology, 2008, Volume: 55, Issue:8

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Agents; Animals; Benzazepines; Biogenic Monoamine

2008
Dopamine receptor agonist- and antagonist-induced behaviors in primates previously treated with dopamine receptor antagonists: the pathogenetic mechanisms of acute oral dyskinesia.
    Clinical neuropharmacology, 1995, Volume: 18, Issue:6

    Topics: Animals; Behavior, Animal; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Macaca; Male; Move

1995